US: 1.917.963.8646 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Global Cardiac Catheters & Guidewires Market 2021: By Product (Cardiac Catheters, Cardiac Guidewires), By End-Use (Hospitals, Clinics, Ambulatory Surgery Centers (ASCs)The Global Cardiac Catheters & Guidewires market size was valued at USD $12.68 Billion in 2020, USD $14.07 Billion in 2021, forecasted to reach USD $15.6 Billion in 2022, and is projected to reach USD $36.9 Billion by 2030, and is anticipated to expand at a CAGR of 10.89% over the forecast period from 2020 to 2030. Global Cardiac Catheters & Guidewires Market is the title of an upcoming report offered by Trusted Business Insights. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global cardiac catheters & guidewires market has been segmented on the basis of product, end-use, as well as regions and countries.Request Covid - 19 Impact
Overview:Cardiac catheterization is a procedure used to diagnose and treat certain cardiovascular conditions. During this process, a long thin tube called a catheter is inserted into an artery or vein, that can be located in your arm, groin, neck, etc., and is then threaded through the bloods vessels to the heart.
Dynamics:The rising incidence of diabetes, as well as the increasing prevalence of cardiovascular diseases on a global-scale are primary factors that are expected to contribute significant to future revenue growth of the global cardiac catheters & guidewires market. Access to favorable reimbursement policies, as well as the introduction of more advanced products in the market are other factors that are contributing to market growth. Another factor that is contributing to market growth is the ever-expanding global geriatric population, where individuals over the age of 65 years are more prone to developing chronic diseases. The adoption of unhealthy lifestyles such as physical inactivity, improper diets, excessive drinking & smoking, etc. is a significant factor that is resulting in the rise of chronic diseases like diabetes and cardiovascular disorders. Furthermore, post the Covid-19 outbreak, a majority of individuals have been forced to remain confined within a predetermined space for long durations of time, resulting in a significant number of them not achieving the necessary physical activity needed for optimal sustenance. This is expected to immensely impact the revenue growth of the global cardiac catheters & guidewires market in the near future. On the other hand, the more immediate effects of this pandemic are that most manufacturing and supply sectors have completely halted their operations, and this will negatively impact revenue growth.
Segmentation of the global cardiac catheters & guidewires market is as follows:In terms of product, the cardiac catheters segment accounted for the majority revenue shares of the global broadband services market in 2019. They are generally used to allow enhanced blood flow and to open blocked vessels. Presently, there are no substitutes for cardiac catheters. Owing to the rising number of cardiovascular diseases on a global level, this segment is expected to register the fastest rate of revenue growth. On the basis of end-use, the hospitals segment accounted for the highest number of revenue shares of the global market in 2019. However, the ambulatory surgery centers segment is expected to register increased demand over the next 10 years.
Regional Segmentation and Analysis:North America accounted for the majority revenue shares of the global cardiac catheters & guidewires market owing to the presence of key market players in the region, technological advancements, and favorable reimbursement programs. However, the APAC is expected to emerge as the fastest-growing market, due to the increasing incidence of chronic diseases and the upsurge of several market players in this region. Emerge™, Maverick ™ , OffRoad™, PT2™, OPTICROSS™, SENSATION PLUS®, OPTITORQUE®, RUNTHROUGH®, Cougar™, Launcher™, Babywire™, AVANTI®, VISITAG™, THERMOCOOL®, CARTO®, Amigo™, CORDIS®, NeoFlex™ , TIP®, EMERALD™, INFINITI®, CORDIS®, Camaro™, R350™, Spectre™, Bandit™, Raider™, Warrior™, Venture®, GuideLiner ®, Turnpike ®, Twin-Pass®, TrapLiner® are the brands covered in this Cardiac Catheters & Guidewires report.
Below are the active patents related to Cardiac Catheters & Guidewires Market.Patent Number: US8048032B2 Coaxial guide catheter for interventional cardiology procedures Abstract A coaxial guide catheter to be passed through guide catheter having a first lumen, for use with interventional cardiology devices that are insertable into a branch artery that branches off from a main artery. The coaxial guide catheter is extended through the lumen of the guide catheter and beyond the distal end of the guide catheter and inserted into the branch artery. The device assists in resisting axial and shear forces exerted by an interventional cardiology device passed through the second lumen and beyond the flexible distal tip portion that would otherwise tend to dislodge the guide catheter from the branch artery. Type: Grant Filed: 2006-05-03 Date of Patent: 2011-11-01 Assignee : Teleflex Life Sciences ULC Patent Number: US8808273B2 Electrophysiology catheter with mechanical use limiter Abstract A catheter for the treatment of tissue, particularly for the treatment of cardiac tissue to alleviate cardiac arrhythmias includes a connector having mechanical use limiter that may be placed in the handle of the catheter or at any point along the electrical connection pathway to an electro-anatomic mapping system and/or ablation system. The mechanical use limiter has a counter wheel and locking pin which when engaged disables the reconnection of the connector to any mated connector after a predetermined number of uses. Type: Grant Filed: 2012-02-10 Date of Patent: 2014-08-19 Assignee : Biosense Webster Israel Ltd Patent Number: EP3125802A1 Ablation catheter and ablation apparatus Abstract The present invention relates to an ablation catheter (1) for the ablation of tissues comprising:- a telescopic tubular body (4) in turn comprising an external tubular body (4a) and an internal tubular body (4b) concentric with each other, and a rod-like guiding element (5) at least partly housed in the internal tubular body (4b) with at least one free end (5a) protruding from the internal tubular body (4b) in correspondence with a distal end of the telescopic body (4); - a positioning head (2, 2", 2 ", 2°, 2*, 2^) and an ablation head (3) in correspondence with the distal end of the telescopic body (4), the positioning head (2,2,2,2,2*,2^) being situated in the proximity of the free end (5a) of the rod-like guide, and the ablation head (3) in the proximity of the positioning head (2, 2, 2, 2°, 2*, 2^), in a remote position with respect to the free end (5a); - a control handpiece at a proximal end of the telescopic body (4) coupled with the guiding element (5), the ablation head (3), the positioning head (2, 2", 2", 2°, 2*, 2^) and the telescopic tubular body (4); wherein the ablation head (3) comprises at least two ablation elements or petals (3a) that can be moved from a rest position in which they are housed in the external tubular body (4a) and an operating position in which they protrude from the external tubular body (4a) like a petal; wherein each of the ablation elements or petals (3a) comprises: - a continuous ablation electrode (3b) which extends without interruption over a circumferential peripheral portion of each petal (3a), substantially along an arc of circumference having a longitudinal axis of the rod-like guiding element (5) as its centre; - two side portions (3c) of the petal (3a), each connected to an end of the ablation electrode (3b), in correspondence with a curved section, the side portions (3c) and the ablation electrode (3b) being integral with each other, formed by means of the same folded metallic conductor, - each ablation petal (3a) being separate and distinct from another ablation petal (3a) of the ablation head, - all the ablation petals (3a) of the ablation head being separately connected to a distinct electric energy generator to cause a radiofrequency ablation in a powered ablation electrode condition (3b). Type: Grant Filed: 2015-03-18 Date of Patent: 2017-02-08 Assignee : ELECTROPHYSIOLOGY FRONTIERS S.P.A. Patent Number: US20130144208A1 Dual-deflecting electrophysiology catheter Abstract An electrophysiology catheter includes a tubular body having a proximal region, a neck region, and a distal region predisposed into a loop and including electrodes. A first deflection wire extends through at least a portion of the proximal region of the catheter body and includes a first flattened section, while a second deflection wire extends through the neck region and at least a portion of the distal region and includes a second flattened section within the neck region. A first activation wire is joined to the flattened section of the first deflection wire, while a second activation wire is joined to the flattened section of the second deflection wire. Thus, forces acting on the first and second activation wires, such as forces imposed by a handle-based actuator, are respectively transmitted to the first and second deflection wires, thereby deflecting the proximal and neck regions, respectively. Type: Grant Filed: 2013-02-04 Date of Patent: 2013-06-06 Assignee : St Jude Medical Atrial Fibrillation Division Inc Patent Number: US20090043191A1 Oct-ivus catheter for concurrent luminal imaging Abstract The invention relates to an apparatus for in vivo imaging. More specifically, the present invention relates to a catheter that incorporates an Optical Coherence Tomography (OCT) system and an Intravascular Ultrasound (“IVUS) system for concurrent imaging of luminal systems, such as imaging the vasculature system, including, without limitation, cardiac vasculature, peripheral vasculature and neural vasculature. Type: Grant Filed: 2008-07-14 Date of Patent: 2009-02-12 Assignee : Volcano Corp Patent Number: US10219780B2 OCT-IVUS catheter for concurrent luminal imaging Abstract The invention relates to an apparatus for in vivo imaging. More specifically, the present invention relates to a catheter that incorporates an Optical Coherence Tomography (OCT) system and an Intravascular Ultrasound (“IVUS) system for concurrent imaging of luminal systems, such as imaging the vasculature system, including, without limitation, cardiac vasculature, peripheral vasculature and neural vasculature. Type: Grant Filed: 2008-07-14 Date of Patent: 2019-03-05 Assignee : Volcano Corp
Below are the leading companies profiled in this Cardiac Catheters & Guidewires Market Report:
Chapter 1 Methodology and Scope